Teva Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Teva Pharmaceuticals

TEVA 20.52

+0.2%

Nov 3 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: flatsville who wrote (282)	7/13/2001 5:58:50 AM
From: Dorine Essey	Read Replies (1) of 340

Teva Pharmaceutical The Israeli drug firm impresses Hilary Thu close $63.34 Kramer of Cisneros Group, who said Up $1.05, 1.7% "Teva is the best way to play both 1.2 million shares generic and branded drugs," citing (TEVA) products such as multiple sclerosis drug Copaxone. David Maris of Credit . Suisse First Boston rates it a buy . with a 12-month target of $76. (END) DOW JONES NEWS 07-12-01 08:52 PM

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next